Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
ConclusionCurrent evidence suggests that the combination of dextromethorphan and bupropion is a well-tolerated, rapid-acting treatment option for adults with MDD. Initial success with AXS-05 supports the mechanistic role of glutamatergeric and sigma 1 signaling in the pathophysiology of MDD.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Bupropion | Clinical Trials | Databases & Libraries | Depression | Neurology | Study | Wellbutrin